NDC 69017-101-01 - ANTI-BLEMISH MATTE PRIMER
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69017-101
- Requested NDC
- 69017-101-01
- Package NDCs from labels
- 69017-101-01, 69017-101-02, 69017-101-03
- Manufacturer
- Jouer Cosmetics LLC
- Effective date
- 2014-06-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ANTI-BLEMISH MATTE PRIMER - Jouer Cosmetics LLC | Jouer Cosmetics LLC | 2014-06-21 | HUMAN OTC DRUG LABEL |
| ANTI-BLEMISH MATTE PRIMER - Jouer Cosmetics LLC | Jouer Cosmetics LLC | 2014-06-21 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69017-101-02 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4faa-60a7-e053-dbdaa90a05bd | 2026988d-7dfa-49ac-bd64-4c2bba197c39 |
| 69017-101-03 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-48cc-60a7-e053-dbdaa90a05bd | fc5eff3e-a7fd-4207-9ef3-3f4e1645fbca |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69017-101-01 | ANTI-BLEMISH MATTE PRIMER | 30 mL in 1 TUBE | LOTION | 30 | 7 | |
| 69017-101-02 | ANTI-BLEMISH MATTE PRIMER | 1 in 1 BOX | LOTION | 1 | 7 | |
| 69017-101-03 | ANTI-BLEMISH MATTE PRIMER | 1 mL in 1 PACKET | LOTION | 1 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69017-101 | ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC] | 7 | Legacy NDC, 2 package rows | 20140621_2026988d-7dfa-49ac-bd64-4c2bba197c39.zip |
| 69017-101 | ANTI-BLEMISH MATTE PRIMER (SALICLYLIC ACID) LOTION [JOUER COSMETICS LLC] | 2 | Legacy NDC, 1 package rows | 20140621_fc5eff3e-a7fd-4207-9ef3-3f4e1645fbca.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SERYNTH GENITAL WARTS REMOVER | SALICYLIC ACID 17% GENITAL WARTS REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a4b8c9d-a9c0-f0a1-e063-6294a90ad9dd | 2026-07-21 | Warnings | O414PZ4LPZ |
| SERYNTH MILIA REMOVER | SALICYLIC ACID 1% MILIA REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a4c3bfa-32ec-c0dd-e063-6394a90ab15c | 2026-07-21 | Warnings | O414PZ4LPZ |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | 059QF0KO0R |
| OURUI ONE FACIAL BUMP REFINING ESSENCE | SALICYLIC ACID 0.25% FACIAL BUMP REFINING ESSENCE | Jiangxi Yudexi Pharmaceutical Co., LTD | 4959bb67-063f-ffa4-e063-6394a90aa01f | 2026-07-20 | Warnings | O414PZ4LPZ |
| Beilloso FACIAL BUMP REFINING ESSENCE | SALICYLIC ACID 1% FACIAL BUMP REFINING ESSENCE | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a461a7a-f5cf-6544-e063-6294a90a00f2 | 2026-07-20 | Warnings | O414PZ4LPZ |
| NATUHEAL WART REMOVER | SALICYLIC ACID 17% WART REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a46ca4f-19df-f148-e063-6394a90a63e6 | 2026-07-20 | Warnings | O414PZ4LPZ |
| OURUI ONE WART COMPLETE Care Kit CORN WART REMOVER | SALICYLIC ACID 17% WART COMPLETE CARE KIT CORN WART REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a47a2ff-4924-eedc-e063-6394a90ab072 | 2026-07-20 | Warnings | O414PZ4LPZ |
| WELLREME Wart Remover | SALICYLIC ACID 17% WART REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4a5e6517-fbe2-0da8-e063-6294a90ad00d | 2026-07-20 | Warnings | O414PZ4LPZ |
| ANIXIKE WART CORN REMOVER PEN | SALICYLIC ACID 17% WART CORN REMOVER PEN | Jiangxi Yudexi Pharmaceutical Co., LTD | 4ac16e3f-7535-4a44-e063-6394a90a75ad | 2026-07-20 | Warnings | O414PZ4LPZ |
| Rukada WART REMOVER Patches | SALICYLIC ACID 17% WART REMOVER PATCHES | Jiangxi Yudexi Pharmaceutical Co., LTD | 524b5d03-af91-d441-e063-6294a90afc95 | 2026-07-20 | Warnings | O414PZ4LPZ |
| Pureskin Seborrheic Dermatitis and Psoriasis Cream | SEBORRHEIC DERMATITIS PSORIASIS CREAM | BENLONG HALL LLC | 36086f7f-8536-417f-a302-37f78288489e | 2026-07-20 | Warnings | O414PZ4LPZ |
| Good Molecules Acne Foaming Cleanser | SALICYLIC ACID | Good Molecules, LLC | 44fa9eda-0910-7d70-e063-6394a90af3a7 | 2026-07-20 | Warnings | O414PZ4LPZ |
| Good Molecules Acne Foaming Cleanser | SALICYLIC ACID | Good Molecules | dec189a2-5f93-7c3e-e053-2a95a90af988 | 2026-07-20 | Warnings | O414PZ4LPZ |
| Komxsum WART REMOVER PATCHES | SALICYLIC ACID 1% WART REMOVER | Jiangxi Yudexi Pharmaceutical Co., LTD | 4dc1da6f-661b-ae95-e063-6394a90aa414 | 2026-07-20 | Warnings | O414PZ4LPZ |
| ADVANCED WART REMOVER | SALICYLIC ACID | Guangzhou ChuanMa International Trading Co.,Ltd. | 41bbda9b-5570-764f-e063-6394a90a6315 | 2026-07-18 | Warnings | O414PZ4LPZ |
| FUNGAL NAIL TREATMENT kit .liquid. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c93390-ee07-4f78-e063-6394a90add42 | 2026-07-17 | Warnings | O414PZ4LPZ |
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | O414PZ4LPZ |
| Clean and Clear Essentials Acne Toner | SALICYLIC ACID | Kenvue Brands LLC | 06cd03e3-6146-65d8-e063-6294a90a1701 | 2026-07-17 | Warnings | O414PZ4LPZ |
| PCA Skin Acne Control Prebiotic Cleanser | SALICYLIC ACID | CP Skin Health Group, Inc. | 56bca675-3e59-815a-e063-6294a90a1d87 | 2026-07-16 | Warnings | O414PZ4LPZ |
| Acne patches | ACNE PATCHES | Shenzhen Hengdasheng Technology Co., Ltd | 5664b9c4-6ae3-4f64-e063-6294a90a825a | 2026-07-14 | Warnings | O414PZ4LPZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.